Search

Your search keyword '"Brown, Allison C."' showing total 137 results

Search Constraints

Start Over You searched for: Author "Brown, Allison C." Remove constraint Author: "Brown, Allison C."
137 results on '"Brown, Allison C."'

Search Results

1. Increased Multidrug-Resistant Salmonella enterica I Serotype 4,[5],12:i:-Infections Associated with Pork, United States, 2009-2018

2. Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018-2019

3. Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents—Georgia, October 2020–July 2022

4. Gram-Negative Bacteria Harboring Multiple Carbapenemase Genes, United States, 2012-2019

5. Descriptive analysis of targeted carbapenemase genes and antibiotic susceptibility profiles among carbapenem-resistant Acinetobacter baumannii tested in the Antimicrobial Resistance Laboratory Network—United States, 2017–2020

6. Antimicrobial Resistance Laboratory Network’s multisite evaluation of the ThermoFisher Sensititre GN7F broth microdilution panel for antimicrobial susceptibility testing

7. 2747. Aztreonam-Avibactam Susceptibility Testing Program for Metallo-β-Lactamase-Producing Enterobacterales collected through the Antimicrobial Resistance Laboratory Network, March 2019 to April 2023

9. Verona Integron-Encoded Metallo-β-Lactamase–Producing Carbapenem-Resistant Pseudomonas aeruginosa Infections in U.S. Residents Associated with Invasive Medical Procedures in Mexico, 2015–2018

12. Vital Signs : Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms — United States, 2006–2017

13. CTX-M-65 Extended-Spectrum [beta]-Lactamase-Producing Salmonella enterica Serotype Infantis, United States

14. Increased Multidrug-Resistant Salmonellaenterica I Serotype 4,[5],12:i:- Infections Associated with Pork, United States, 2009–2018

15. Immediate Closures and Violations Identified During Routine Inspections of Public Aquatic Facilities — Network for Aquatic Facility Inspection Surveillance, Five States, 2013

16. Epidemiology of salmonella enterica serotype Dublin infections among humans, United States, 1968-2013

17. 1941. Describing the immune response kinetics to mRNA COVID-19 vaccines among previously SARS-CoV-2–infected and –uninfected nursing home residents, a prospective longitudinal observational cohort evaluation—Georgia, October 2020 – September 2021

20. Increased Multidrug-Resistant Salmonella enterica I Serotype 4, [5],12:i: -Infections Associated with Pork, United States, 2009-2018.

21. Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG

22. Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort—Georgia, October 2020–April 2021

23. Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient Hemodialysis

24. Descriptive evaluation of antibody responses to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in plasma and gingival crevicular fluid in a nursing home cohort—Arkansas, June–August 2020

25. Detection and Characterization of Targeted Carbapenem-Resistant Health Care-Associated Threats: Findings from the Antibiotic Resistance Laboratory Network, 2017 to 2019

26. Development and validation of an enzyme immunoassay for detection and quantification of SARS-CoV-2 salivary IgA and IgG

27. Absence of SARS-CoV-2 infections among patients with end-stage renal disease following facility-wide testing in four outpatient hemodialysis facilities

28. A Comparison of Less Invasive SARS-CoV-2 Diagnostic Specimens in Nursing Home Residents — Arkansas, June–August 2020

29. Aztreonam-Avibactam Susceptibility Testing Program for Metallo-Beta-Lactamase-Producing Enterobacterales in the Antibiotic Resistance Laboratory Network, March 2019 to December 2020

30. Carbapenemase production among less-common Enterobacterales genera: 10 US sites, 2018

31. Repeated antigen testing among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)–positive nursing home residents

32. Descriptive evaluation of antibody responses to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in plasma and gingival crevicular fluid in a nursing home cohort—Arkansas, June–August 2020

33. Infectious Period of Severe Acute Respiratory Syndrome Coronavirus 2 in 17 Nursing Home Residents—Arkansas, June–August 2020

34. Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales

36. Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States in 2017 and 2018

37. Validation of Aztreonam-Avibactam Susceptibility Testing Using Digitally Dispensed Custom Panels

41. Notes from the Field:Verona Integron-Encoded Metallo-β-Lactamase–Producing Carbapenem-ResistantPseudomonas aeruginosaInfections in U.S. Residents Associated with Invasive Medical Procedures in Mexico, 2015–2018

44. Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales.

46. Acanthamoeba Keratitis among Rigid Gas Permeable Contact Lens Wearers, United States, 2005–2011

48. Comparative Analysis of Extended-Spectrum-β-Lactamase CTX-M-65-Producing Salmonella enterica Serovar Infantis Isolates from Humans, Food Animals, and Retail Chickens in the United States

49. CTX-M-65 Extended-Spectrum β-Lactamase-Producing Salmonella enterica Serotype Infantis, United States1.

50. CTX-M-65 Extended-Spectrum β-Lactamase-Producing Salmonella enterica Serotype Infantis, United States1.

Catalog

Books, media, physical & digital resources